Brief Report: Protease Inhibitors Versus Nonnucleoside Reverse Transcriptase Inhibitors and the Risk of Cancer Among People With HIV.
Coburn SB, Pimentel N, Leyden W, Kitahata M, Moore RD, Althoff KN, Gill MJ, Lang R, Horberg MA, D'Souza G, Hussain SK, Dubrow R, Novak RM, Rabkin CS, Park LS, Sterling TR, Neugebauer RS, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.
Coburn SB, et al. Among authors: sterling tr.
J Acquir Immune Defic Syndr. 2024 Aug;96(4):393-398. doi: 10.1097/QAI.0000000000003436.
J Acquir Immune Defic Syndr. 2024.
PMID: 39720558